170 related articles for article (PubMed ID: 1967069)
1. In vitro immunosuppressive effect: a comparative study between deoxymethylspergualin and cyclosporin A, on human lymphocyte responses.
Jiang H; Takahara S; Kokado Y; Ishibashi M; Sonoda T
J Clin Lab Immunol; 1990 Oct; 33(2):75-81. PubMed ID: 1967069
[TBL] [Abstract][Full Text] [Related]
2. The in vitro immunosuppressive effect of deoxymethylspergualin in man as compared with FK506 and cyclosporine.
Takahara S; Jiang H; Takano Y; Kokado Y; Ishibashi M; Okuyama A; Sonoda T
Transplantation; 1992 Apr; 53(4):914-8. PubMed ID: 1373537
[TBL] [Abstract][Full Text] [Related]
3. In vitro kinetic study of the immunosuppressive effect of deoxymethylspergualin on human peripheral blood mononuclear cells.
Takano Y; Takahara S; Jiang H; Kameoka H; Kokado Y; Moutabarrik A; Ishibashi M; Okuyama A
J Clin Lab Immunol; 1991 Apr; 34(4):163-9. PubMed ID: 1668283
[TBL] [Abstract][Full Text] [Related]
4. In vitro immunosuppressive effect of deoxymethylspergualin.
Jiang H; Takahara S; Takano Y; Machida M; Iwasaki A; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Sonoda T
Transplant Proc; 1990 Aug; 22(4):1633-7. PubMed ID: 2143857
[No Abstract] [Full Text] [Related]
5. Deoxyspergualin, a novel immunosuppressant, markedly inhibits human mixed lymphocyte reaction and cytotoxic T-lymphocyte activity in vitro.
Fujii H; Takada T; Nemoto K; Abe F; Fujii A; Talmadge JE; Takeuchi T
Int J Immunopharmacol; 1992 May; 14(4):731-7. PubMed ID: 1387869
[TBL] [Abstract][Full Text] [Related]
6. [Study of immunosuppressive mechanism of deoxymethylspergualin in vitro].
Uemura T
Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1301-7. PubMed ID: 8355445
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive mechanism of action of deoxymethylspergualin--a human in vitro assay.
Takano Y; Takahara S; Jiang H; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Okuyama A
Transplant Proc; 1992 Aug; 24(4):1372-4. PubMed ID: 1386697
[No Abstract] [Full Text] [Related]
8. UVB irradiation of human-derived peripheral blood lymphocytes induces apoptosis but not T-cell anergy: additive effects with various immunosuppressive agents.
Yaron I; Yaron R; Oluwole SF; Hardy MA
Cell Immunol; 1996 Mar; 168(2):258-66. PubMed ID: 8640873
[TBL] [Abstract][Full Text] [Related]
9. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro.
Comoli P; Montagna D; Moretta A; Zecca M; Locatelli F; Maccario R
J Immunol; 1995 Dec; 155(12):5506-11. PubMed ID: 7499831
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF.
Hess AD; Tutschka PJ; Santos GW
J Immunol; 1982 Jan; 128(1):355-9. PubMed ID: 6459374
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the sensitivity of pig and human peripheral blood mononuclear cells to the antiproliferative effects of traditional and newer immunosuppressive agents.
Wright DC; Deol HS; Tuch BE
Transpl Immunol; 1999 Sep; 7(3):141-7. PubMed ID: 10608297
[TBL] [Abstract][Full Text] [Related]
12. In vitro study of deoxymethylspergualin on functions of lymphocytes and bone marrow cells from healthy volunteers.
Kawasaki C; Okamura S; Shimoda K; Nemoto K; Niho Y
J Antibiot (Tokyo); 1995 Mar; 48(3):243-7. PubMed ID: 7730159
[TBL] [Abstract][Full Text] [Related]
13. Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.
Hess AD; Tutschka PJ
J Immunol; 1980 Jun; 124(6):2601-8. PubMed ID: 6445383
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of the effects of betamethasone butyrate propionate, vitamin D3 derivatives, and cyclosporine on human lymphocyte-proliferation stimulated with a hemolytic streptococci-derived superantigen.
Arai K; Uchiyama T; Okubo Y; Tsuboi R; Oka K; Hirano T
Eur J Pharmacol; 2007 Oct; 571(2-3):222-30. PubMed ID: 17628528
[TBL] [Abstract][Full Text] [Related]
15. Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.
Zhou L; Ritchie D; Wang EY; Barbone AG; Argentieri D; Lau CY
J Immunol; 1994 Dec; 153(11):5026-37. PubMed ID: 7963563
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated lympholysis in vitro. Independence of mixed lymphocyte reactions and T-cell mitogen responses from the in vitro generation of cytotoxic effectors in primary immunodeficiency diseases.
Mawas C; Sasportes M; Charmot D; Christen Y; Dausset J
Clin Exp Immunol; 1975 Apr; 20(1):83-92. PubMed ID: 128428
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti-interleukin-2 receptor antibody and cyclosporin A on human T cell proliferation in primary mixed lymphocyte reaction.
Oiwa K; Sakagami K; Orita K
Hiroshima J Med Sci; 1989 Mar; 38(1):1-6. PubMed ID: 2526799
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human macrophage-colony stimulating factor suppresses the mouse mixed lymphocyte reaction.
Sakurai T; Yamada M; Simamura S; Motoyoshi K
Cell Immunol; 1996 Jul; 171(1):87-94. PubMed ID: 8660842
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of dialysis patient lymphocyte responses to cyclosporine.
Briggs WA; Gao ZH; Xing JJ; Scheel PJ; Gimenez LF; Burdick JF
Transplant Proc; 1996 Aug; 28(4):2063-5. PubMed ID: 8769157
[No Abstract] [Full Text] [Related]
20. Development of precytotoxic T cells in cyclosporine-suppressed mixed lymphocyte reactions.
Hooton JW; Miller CL; Helgason CD; Bleackley RC; Gillis S; Paetkau V
J Immunol; 1990 Feb; 144(3):816-23. PubMed ID: 2136900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
